Taurine effects on emotional learning and memory in aged mice: Neurochemical alterations and differentiation in auditory cued fear and context conditioning

Advances in Experimental Medicine and Biology

Volumn 775, Issue , 2013, Pages 195-214

  Neuwirth, Lorenz S ^a,b,c   Volpe, Nicholas P ^a   El Idrissi, Abdeslem ^a,b,c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; MERCAPTAMINE; SOMATOSTATIN; TAURINE; ANXIOLYTIC AGENT;

ACOUSTIC STRESS; ACUTE DRUG ADMINISTRATION; AGED; AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; AUDITORY STIMULATION; AVERSIVE BEHAVIOR; CHRONIC DRUG ADMINISTRATION; CONDITIONING; CONTEXT CONDITIONING; CONTROLLED STUDY; DRUG MECHANISM; EMOTIONAL LEARNING; FEAR; FOOTSHOCK; GABAERGIC SYSTEM; HYPERSENSITIVITY; INHIBITION (PSYCHOLOGY); LEARNING; LIMBIC SYSTEM; MALE; MEMORY; MOUSE; NERVE CELL EXCITABILITY; NERVE PROJECTION; NEUROCHEMISTRY; NEUROPROTECTION; NOCICEPTION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; STIMULUS RESPONSE; TRANQUILIZING ACTIVITY; AGING; ANIMAL; DRUG EFFECT; EMOTION; HEARING; LEARNING CURVE; PAIN; PAIN THRESHOLD; PAIRED ASSOCIATE LEARNING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STIMULATION;

AGING; ANIMALS; ANTI-ANXIETY AGENTS; AUDITORY PERCEPTION; CONDITIONING (PSYCHOLOGY); CUES; EMOTIONS; FEAR; LEARNING CURVE; MEMORY; MICE; PAIN; PAIN THRESHOLD; PAIRED-ASSOCIATE LEARNING; PHYSICAL STIMULATION; TAURINE;

MLCS; MLOWN;

EID: 84878787911     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6130-2_17     Document Type: Article

References (58)

1. Baskhit C, Swerdlow N (1986) Behavioral changes following central injection of cysteamine in rats. Brain Res 365:159-163
2. Barad M, Gean PW, Lutz B (2006) The role of the amygdala in the extinction of conditioned fear. Biol Psychiatry 60:322-328
3. Barbeau A, Inoue N, Tsukada Y, Butterworth RF (1975) The neuropharmacology of taurine. Life Sci 17(5):669-677
4. Baskin SI, Hinkamp DL, Marquis WJ, Tilson HA (1974) Effects of taurine on psychomotor activity in the rat. Neuropharmacology 13(7):591-594
5. Ben-Ari Y (2002) Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci 3(9):728-739
6. Besson JM (1999) The neurobiology of pain. Lancet 353:1610-1615
7. Blanchard RJ, Blanchard DC (1969) Crouching as an index of fear. J Comp Physiol Psychol 67:370-375
8. Chaudhury D, Colwell CS (2002) Circadian modulation of learning and memory in fear-conditioned mice. Behav Brain Res 133:95-108
9. Chen SW, Kong WX, Zhang YJ, Li YL, Mi XJ, Mu XS (2004) Possible anxiolytic effects of taurine in the mouse elevated plus maze. Life Sci 75(12):1503-1511
10. DeNoble VJ, Helper DJ, Barto RA (1989) Cysteamine-induced depletion of somatostatin produces differential cognitive deficits in rats. Brain Res 482:42-48
11. De Oca BM, DeCola JP, Maren S, Fanselow MS (1998) Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci 18:3426-3432
12. El Idrissi A, Iskra BS, Neuwirth LS (2011) Neurobehavioral effects of taurine in Fragile X syndrome. In: El Idrissi A, L'Amoreaux WJ (eds) Taurine in health and disease, vol 644. Plenum Press, New York, pp 306-345
13. El Idrissi A, Neuwirth LS, L'Amoreaux WL (2010) Taurine regulation of short term synaptic plasticity in Fragile X mice. J Biomed Sci 17(Suppl 1):S15
14. El Idrissi A, Boukarrou L, Heany W, Malliaros G, Sangdee C, Neuwirth LS (2009) Effects of taurine on anxiety-like and locomotor behavior of mice. In: Azuma J, Schaffer SW, Takashi I (eds) Taurine 7: taurine for the future healthcare, vol 643. Springer, New York, pp 207-215
15. El Idrissi A (2008) Taurine improves learning and retention in aged mice. Neurosci Lett 436:19-22
16. El Idrissi A, L'Amoreaux WJ (2008) Selective resistance of taurine-fed mice to isoniazid-potentiated seizures: in vivo functional test for the activity of glutamic acid decarboxylase. Neuroscience 156(3):693-699
17. El Idrissi A, Ding X-H, Scalia J, Trenkner E, Brown WT, Dobkin C (2005) Decreased GABAA receptor expression in the seizure-prone fragile X mouse. Neurosci Lett 377:141-146
18. El Idrissi A, Trenkner E (2004) Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29:189-197
19. El Idrissi A, Messing J, Scalia J, Trenkner E (2003) Prevention of epileptic seizures through taurine. In: Lombardini JB, Schaffer SW, Azuma J (eds) Taurine 5 beginning the 21st century, Adv Exp Med Biol, Kluwer Press, New York, 526, pp 515-525
20. El Idrissi A, Trenkner E (1999) Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19:9459-9468
21. Engine E, Treit D (2009) Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors. Psychopharmacology (Berl) 206:281-289
22. Fanselow MS (1990) Factors governing one-trial contextual conditioning. Anim Learn Behav 18:264-270
23. Faron-Górecka A, Kusmider M, Zurawek D, Gaska M, Gruca P, Papp M, Dziedzicka-Wasylewska M (2011) P.1.028 Serum levels of somatostatin-28 and its binding sites in medial habenular nucleus differentiate rats responding and non responding to chronic mild stress. Eur Neuropsychopharmacol 21:S131-S132. doi:10.1016/S0924-977X(11)70151-1
24. Haroutunian V, Mantin R, Campbell GA, Tsuboyama GK, Davis KL (1987) Cysteamine-induced depletion of central somatostatin-like immunoactivity: effects on behavior, learning, memory, and brain neurochemistry. Brain Res 403:234-242
25. Hayashi M, Oshima K (1986) Neuropeptides in cerebral cortex of macaque monkey (Macaca fuscata fuscata): regional distribution and ontogeny. Brain Res 364:360-368
26. Hayes KC, Carey SY, Schmidt SY (1975) Retinal degeneration associated with taurine deficiency in the cat. Science 188(4191):949-951
27. Hruska RE, Thut PD, Huxtable RJ, Bressler R (1975) Suppression of conditioned drinking by taurine and related compounds. Pharmacol Biochem Behav 3(4):593-599
28. Huxtable RJ, Peterson A (1989) Sodium-dependent and sodium-independent binding of taurine to rat brain synaptosomes. Neurochem Int 14(1):79-84
29. Ikeda HC (1977) Effects of taurine on alcohol withdrawal. Lancet 2(8036):509
30. Joseph MH, Emson PC (1976) Taurine and cobalt induced epilepsy in the rat: a biochemical and electrocorticographic study. J Neurochem 27:1495-1501
31. Khalilov I, Le Van Quyen M, Gozlan H, Ben-Ari Y (2005) Epileptogenic actions of GABA and fast oscillations in the developing hippocampus. Neuron 48:787-796
32. Kluge C, Stoppel C, Szinyei C, Stork O, Pape HC (2008) Role of the somatostatin system in contextual fear memory and hippocampal synaptic plasticity. Learn Mem 4:252-260
33. Knapska E, Nikolaev E, Boguszewski P, Walasek G, Blaszczyk J, Kaczmarek L, Werka T (2006) Between-subject transfer of emotional information evokes specific pattern of amygdala activation. Proc Natl Acad Sci U S A 103(10):3858-3862
34. Kong WX, Chen SW, Li YL, Zhang YJ, Wang R, Min L, Mi X (2006) Effects of taurine on rat behaviors in three anxiety models. Pharmacol Biochem Behav 83(2):271-276
35. Krantic S, Goddard I, Saveanu A, Giannetti N, Fombonne J, Cardoso A, Jaquet P, Enjalbert A (2004) Novel modalities of somatostatin actions. Eur J Endocrinol 151:643-655
36. Kusmider M, Faron-Górecka A, Zurawek D, Gaska M, Gruca P, Papp M, Dziedzicka-Wasylewska M (2011) P.1.029 Alterations in somatostatin binding sites in brains of rats subjected to chronic mild stress. Eur Neuropsychopharmacol 21:S132. doi:10.1016/S0924-977X(11)70152-3
37. LeDoux JE (2000) Emotion circuits in the brain. Annu Rev Neurosci 23:155-184
38. LeDoux JE (1994) Emotion, memory and the brain. Sci Am 270:50-57
39. Levinskaya N, Trenkner E, El Idrissi A (2006) A Increased GAD-positive neurons in the cortex of taurine-fed mice. Adv Exp Med Biol 583:411-417
40. Lydiard RB, Ballenger JC, Rickles K, for the Abecarmil Work Group. (1997) A double-blind evaluation of the safety and efficacy of abecarmil, alprazolam and placebo in outpatients with generalized anxiety disorder. J. Clin. Psychiatry 58:11-18
41. Martin EI, Ressler KJ, Binder E, Nemeroff CB (2009) The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin North Am 32:549-575
42. Matsuoka N, Maeda N, Yamaguchi I, Satoh M (1994) Possible involvement of brain somatostatin in the memory formation of rats and cognitive enhancing action of FR121196 in passive avoidance task. Brain Res 642:11-19
43. McLay RN, Pan W, Kastin AJ (2001) Effects of peptides on animal and human behavior: a review of studies published in the first twenty years of the journal Peptides. Peptides 22:2181-2255
44. Orsini CA, Maren S (2012) Neural and cellular mechanisms of fear and extinction memory formation. Neursci Biobehav Rev 2012(36):1773-1802
45. Perry TL (1976) Hereditary mental depression with taurine deficiency: further studies, including a therapeutic trial of taurine administration. In: Huxtable R, Barbeau A (eds) Taurine, Adv Exp Med Biol, Raven Press, New York, 526, pp 365-374
46. Riback CE, Lauterborn JC, Navetta MS, Gall CM (1993) The inferior colliculus of GEPRs contains greater numbers of cells that express glutamate decarboxylase (GAD67) mRNA. Epilepsy Res 14:105-113
47. Rickels K, Schweizer E (1997) The clinical presentation of generalized anxiety in primary-care setting: practical concepts of classification and management. J Clin Psychiatry 58:4-9
48. Sanberg PR, Fibiger HC (1979) Impaired acquisition and retention of a passive avoidance response after chronic ingestion of taurine. Psychopharmacology 29(62)1:97-99
49. Sanberg PR, Ossenkopp KP (1977) Dose-response effects on some open-field behaviors in the rat. Psychopharmacology (Berl) 53(2):207-209
50. Schettini G, Florio T, Magri G, Grimaldi M, Meucci O, Landolfi E, Marino A (1998) Somatostatin and SMS 201-995 reverse the impairment of cognitive functions induced by cysteamine depletion of brain somatostatin. Eur J Pharmacol 151:399-407
51. Sotres-Bayon F, Cain CK, LeDoux JE (2006) Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry 60:329-336
52. Suge R, Nobuo H, Furube M, Yamamoto T, Hirayama A, Hirano S, Nomura M (2007) Specific timing of taurine supplementation affects learning ability in mice. Life Sci 81:1228-1234
53. Szabo S, Reichlin S (1981) Somatostatin in rat tissues is depleted by cysteamine administration. Endocrinology 109:2255-2257
54. Van Nobelen M, Kokkinidis L (2006) Amygdaloid gaba, not glutamate neurotransmission mRNA transcription controls foot-shock associated arousal in the acoustic startle paradigm. Neuroscience 137:707-716
55. Vecsei L, Widerlov E (1990) Preclinical and clinical studies with cysteamine and pantethine related to the central nervous system. Prog Neuropsychopharmacol Biol Psychiatry 14:835-862
56. Vecsei L, Pavo I, Zsigo J, Penke B, Widerlov E (1989) Comparative studies of somatostatin-14 and some of its fragments on passive avoidance behavior, open field activity and on barrel rotation phenomenon in rats. Peptides 10:1153-1157
57. Wehner JM, Radcliffe RA (2004) Cued and contextual fear conditioning in mice. Behav Neurosci 27:8.5C.1-8.5C.14
58. Wittchen HU (2002) Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety 16:162-171